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Gronpeace Apology
In a September alo to Roya Dutch Shell, Greenpeace International admitted it
may have gone overbiartdwen it came to estimating the amount ofpotentially haz-
ardous petoleum that would have been released by ocean disposal ofthe company's
Brent Spar oili rig e environmental group had used tactics such as mounting the
rig durin its wng to a dumping site in the Outer Hebrides off the coast of
Scotlad andprovoking an inte boycott ofShellgasoline to force the compa-
y to abandon plans to dispose ofthe rig at sea, saying that doing so would be very
haadost theevrnet
Green orginal estimated that sinking the oil rigwould release 5,500 met-
rc tons o minto the ocean ecosystems. In his written apology, Greenpeace
Eeui iet Lord Peter Melchett said that that figure was simply wrong. The
erneous estimat was basd on an improperly conducted storage tank sample,
ccording Melcett.Greenpeace did notoffer arevised estimate.
l ga in to politl and economic pressure in June and changed its plan to
dup the rig which had been approved by Great Britain, to a plan for on-land
decommissioning. The company-will conduct an environmental impact study on
mea of dispos ofthe rigbefremaking adec;sion about its final fate.
in Boolaroo, who said that lead exposures
in her area of Broken Hill and in other
smelting towns created second-class citi-
zens.
An AMA/ACF/Greenpeace coalition
will raise the profile of environmental
health. Within the political arena, the
coalition will target community "right to
know" issues, including a National
Pollutant Inventory. Caswell said that
prior to establishment of the coalition,
"There was a lack ofgovernment commit-
ment to address accelerating environmental
degradation and a vacuum in public policy
development to address long-term environ-
mental degradation, particularly water
resources and population issues."
The coalition, which toured "chemical
hot spots," including cotton growing areas
where pesticide use is heavy in New South
Wales and contaminated land sites in
Melbourne, Victoria, before the summit,
endorsed the need for a national health
effects reporting system for chemicals. The
register would include agricultural, indus-
trial, and household chemicals and, using
coalition established criteria, would docu-
ment instances where doctors believed
patients had suffered adverse effects from
exposures. Weedon said, "We are con-
cerned that there are medical effects from
exposures to chemicals following improper
use and occupational or accidental expo-
sures." The Australian Council of Trade
Unions (ACTU) recently completed a
study that indicates that chemical expo-
sures are a major cause of workplace
injuries (an estimated 2,200 deaths per
year).
Senator John Coulter, a research scien-
tist and environment spokesperson for the
Australian Democratic Party, focused on
degradation of national water resources,
particularly overuse for irrigation, which
has resulted in extensive salination ofsome
of Australia's best agricultural land.
"Australia has the unenviable reputation of
the world's largest outbreak of blue-green
algae in the Murray River system in 1993,"
Coulter said
John Donovan, principal medical advi-
sor to the Australian Institute of Health
and Welfare in Canberra, provided a sum-
mary of the results from the National
Children's Blood Lead Survey. According
to Donovan, more than 93% of the chil-
dren sampled between April and June
1995 had blood lead levels lower than the
National Health and Medical Research
Council target for all children (below 10
pg/dl by 1998). Donovan also indicated
that for the remaining 7% of children,
ambient air pollution and lead paint in
housing could not adequately account for
the observed levels. There was a strong cor-
relation between blood lead levels and lev-
els of household dust in homes of these
children, with dustier homes associated
with elevated blood lead values. Other sig-
nificant correlations existed with child-
hood pica (hand-to-mouth behavior) and
parental smoking in the home.
The Australian Capital Territory
Government Environment Minister, Gary
Humphries, identified arsenic as a new
urban problem. Canberra, the national
capital that was built on sheep country in
1901, has recently discovered old animal
dip sites in residential areas. "The problem
is much more than the physiological health
of the residents," said Humphries, "the
issue is clearly an emotive one and goes
right to the heart ofthe community's per-
ceptions of risk." Humphries stressed the
need to maintain community involvement
through information campaigns and close
consultation and participation in the man-
agement ofthe remediation.
Erin Jackson, head of Greenpeace's
Climate Impacts Unit, spoke of the
increasing international concern that the
long-term impacts ofclimate change repre-
sent one of the greatest challenges for
humanity. Increased frequency, severity,
and wider distribution of crop losses,
spread ofinfectious diseases into new envi-
ronments, heat waves, and flooding from
rising sea levels will bring a generation of
"environmental refugees," Jackson said.
The next major environmental health
gathering in Australia will take place at the
Intergovernmental Forum on Chemical
Safety in Canberra on 3-8 March 1995.
Carbon Monoxide-Heart
Failure Link
Every year, hospitals in the United States
admit roughly a million patients with con-
gestive heart failure, a condition in which
the heart pumps less blood than normal.
Researchers now think tens ofthousands of
these admissions may be linked to carbon
monoxide (CO) in the air.
A study in the October issue of the
American Journal ofPublic Health reports
that increases in outdoor CO may cause
shortness ofbreath in people with conges-
tive heart failure, sending them to the hos-
pital. "Across the country, with each day
that showed an increase in carbon monox-
ide, we saw an increase in hospital admis-
sions," says lead author Robert D. Morris,
an epidemiologist at the Medical College
of Wisconsin in Milwaukee. "The consis-
tency was striking."
Carbon monoxide, a common air pol-
lutant, results from burning hydrocarbon-
based fuels. According to the EPA, motor
vehicles generate over 90% of urban CO
pollution. Car tailpipes emit the gas direct-
ly into the air. Other CO sources include
factory emissions, gas stoves, and tobacco
smoke.
Carbon monoxide presumably aggra-
vates heart disease by binding to hemoglo-
bin, thereby hindering oxygen transport
through the blood. "In particular, carbon
monoxide appears to affect congestive
heart failure patients who also have lung
disease," says Morris. In the study, 15% of
hospitalized patients had both lung and
heart disease. Nationwide, an estimated 3
million people, most over the age of 65,
suffer from congestive heart failure.
The study is one ofthe first to explore
outdoor the effect ofCO on heart disease.
Morris and colleagues compared Medicare
data on heart failure hospitalizations with
air pollution readings collected by the EPA
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in seven U.S. cities: Chicago, Detroit,
Houston, Los Angeles, Milwaukee, New
York, and Philadelphia. Looking at data
for 1986-1989, the researchers found that
3,250 (about 5.7%) of the cities' annual
congestive heart failure hospitalizations
correlatedwith an increase in air CO.
Thomas E. Dahms, a cardiovascular
physiologist at St. Louis University who
has studied CO, cautions that the study's
retrospective approach is limited. "For one
thing, congestive heart failure is a loosely
defined diagnosis," Dahms says. "To vali-
date its consistency between hospitals,
you'd have to do some spot checking of
patient records."
Dahms also worries whether air pollu-
tion readings accurately reflect an individ-
ual's exposure to CO. "There have been a
number ofstudies trying to relate personal
CO exposure levels to air readings picked
up at monitoring stations 50 to 100 feet
offthe ground," he says. "So far, there has
been littlevalidation in relating the two."
ButJoel Schwartz, an epidemiologist at
the Harvard School ofPublic Health who
wrote an editorial accompanying the study,
says the work is informative. "There is cer-
tainly a chance for misdiagnosis when
looking across cities," Schwartz says. "But
within any one city's analysis, it shouldn't
be a problem." Such misdiagnosis is
absorbed during statistical analysis, he says.
Schwartz adds that, despite inconsistencies,
there is a clear link between personal expo-
sure and air pollution readings: "The real
question is, IfI took everyone in this city,
averaged their personal exposure to CO
and correlated that, day to day, with the
average outdoor air pollution readings,
what would I find? Would the averages go
up and down together? We won't know
until we do more studies."
Morris agrees his findings are prelimi-
nary. "Clearly, this study raises as many
questions as it answers," he says. One
question involves the amount of CO that
exacerbates heart problems. The health
effects cited in this study occurred below
federally permissible CO levels. "From the
lowest levels of carbon monoxide, we are
seeing an increase in hospital admissions
with rising pollutant," Morris says. "If
future studies do establish a minimum CO
effect threshold, that may impact EPA air
standards."
The EPA attempts to control CO pol-
lution by regulating motor vehicle emis-
sions. The Clean AirAct of 1990 strength-
ened tests for auto emission standards and
required oxygenated gasolines, with addi-
tives to improve fuel efficiency, for metro-
politan areas with high CO levels.
Morris next plans to study exposure to
another common auto pollutant: fine com-
bustion particles. "It's possible that this
pollutant, along with carbon monoxide,
contributes to the heart failure admissions
we reported," Morris says. "Nowwe've got
to separate the two pollutants and find out
how important each one is."
Barking up the Right Tree?
People may now have one more reason to
save trees: they might someday save your
life. In a recent study at the University of
Illinois at Chicago, a compound called
betulinic acid, derived from the bark of
white birch trees, has been shown to halt
the growth ofmelanoma cancer cells. More
importandy, the compound selectively tar-
gets these cells, providing hope that a
chemotherapeutic drug developed from
betulinic acid will have very few side
effects.
The compoundwas originally extracted
from the bark ofan African tree, Ziziphus
mauritiana lam (Rhamnaceae). It was later
found in the bark of the common white
birch. Unlike extracting taxol, another
chemotherapeutic substance obtained from
tree bark, the process to extract betulinic
acid is relativelysimple, involving a chloro-
form extraction andcrystallization process.
Betulinic acid was shown to be ahighly
effective antitumor agent in a study pub-
lished in the October 1995 issue ofNature
Medicine. The study reported on a success-
ful series of cell culture experiments with
four human melanoma cell lines (derived
from lymph node, lung fluid, liver, and
skin). The growth of the cell cultures was
specifically inhibited using half the maxi-
mal effective doses of 1-5 micrograms per
milliliter. Researchers tested the compound
in immune-suppressed mice that had been
induced to develop human melanomas. In
these experiments, tumor growth was
either inhibited significantly or halted in
the treated group. A drug called DTIC
(dacarbazine), commonly used to treat
human melanoma, was used as one ofthe
positive controls. The betulinic acid-treat-
ed mice showed three times greater tumor
inhibition than the DTIC-treated mice.
"These results are very encouraging,"
says John Pezzuto, director ofthe Program
ofCollaborative Research at the University
of Illinois. "Of the thousands of agents
screened, betulinic acid is one of the best
compounds to come out ofour lab in the
last five years." A potentially beneficial
property of betulinic acid is that it does
not appear to affect other human cancer
cell types, suggesting a unique specificity
for melanoma that may shed light on the
mechanisms of this disease. Current anti-
neoplastic agents such as captothecin,
taxol, and vinblastine are toxic to multiple
cell types, resulting in damage to normal
tissue.
Several pharmaceutical companies have
shown interest in funding the development
ofbetulinic acid. According to Pezzuto, in
vivo tests are continuing and will be fol-
lowed by rigorous toxicity testing. If the
results are positive, an investigative new
drug application may be filed with the
FDA as early as 1996, allowing human
dinical trials to begin.
In addition to treating malignant
melanoma, a disease that strikes 1 in 90
Americans, the compound may someday
be used to prevent and treat other skin
cancers. Skin cancers, with about 800,000
new cases per year, are the most frequent
type of cancer in the United States. The
compound's efficacy will eventually also be
tested against a variety of other tumor
types such as neuroblastoma, a type of
brain tumor. In addition, because of its
emerging excellent safety profile, Pezzuto
envisions betulinic acid's potential useful-
ness in consumer products such as sun-
screens.
According to one expert, it may be too
soon to tell the real potential for this bark
extract. Antonio Buzaid, a melanoma spe-
cialist at the University of Texas MD
Anderson Cancer Center, recently com-
mented in Science News that "in most
cases, such effective drugs don't pan out in
people." This caution is echoed by Don
Morton, medical director and chief of
surgery at the John Wayne Cancer
Institute, who conducts research on
Made in the shade. A substanc'e isolated from
the bark of white birch trees shows promise
for treating melanomas.
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